Bio Green Med Solution, Inc. (BGMS)
NASDAQ: BGMS · Real-Time Price · USD
0.6403
-0.0698 (-9.83%)
At close: Nov 13, 2026, 4:00 PM EST
0.6440
+0.0037 (0.58%)
After-hours: Nov 13, 2026, 4:34 PM EST

Bio Green Med Solution Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2.230.750.040.42--
Revenue Growth
2658.03%1637.21%-89.76%---
Cost of Revenue
2.591.426.5618.72--
Gross Profit
-0.35-0.67-6.52-18.3--
Selling, General & Admin
2.777.725.396.727.387.46
Research & Development
0.030.040.090.4320.2714.93
Operating Expenses
2.87.755.497.1527.6622.39
Operating Income
-3.16-8.43-12-25.45-27.66-22.39
Interest & Investment Income
0.110.060.010.270.210.02
Currency Exchange Gain (Loss)
0.120.07-0.05-0.410.230.04
Other Non Operating Income (Expenses)
0.430.350.050.051.30.14
EBT Excluding Unusual Items
-2.51-7.94-11.99-25.55-25.92-22.19
Gain (Loss) on Sale of Assets
4.954.95----
Pretax Income
2.44-2.99-11.99-25.55-25.92-22.19
Income Tax Expense
0.050.01-0.78-3-4.72-3.73
Net Income
-1.66-3-11.21-22.56-21.2-18.46
Preferred Dividends & Other Adjustments
9.611.09-0.20.20.2
Net Income to Common
-11.26-14.09-11.21-22.76-21.4-18.66
Net Income Growth
------
Shares Outstanding (Basic)
620---
Shares Outstanding (Diluted)
620---
Shares Change
503.91%9692.40%----
EPS (Basic)
-2.01-6.45-502.46---
EPS (Diluted)
-2.01-6.45-502.46---
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
--4.77-7.99-16.12-20.83-18.57
Free Cash Flow Per Share
--2.18-358.07---
Gross Margin
-15.80%-90.09%----
Operating Margin
-141.27%-1128.11%-27916.28%-6060.24%--
Profit Margin
-504.07%-1886.48%-26074.42%-5418.10%--
Free Cash Flow Margin
--638.55%-18581.40%-3837.62%--
EBITDA
-3.15-8.42-12-25.42-27.62-22.35
D&A For EBITDA
00.010.010.030.030.04
EBIT
-3.16-8.43-12-25.45-27.66-22.39
Revenue as Reported
2.230.750.040.42--